University of Minnesota starts clinical trials for Covid 19 along with Laurus Labs and Rising Pharma

▴ University of Minnesota
The companies will work with the University of MInnesota to explore hydroxychloroquine as preventive treatment for coronavirus disease.
Laurus Labs and Rising Pharma joins hands for clinical trial of Covid 19 vaccine .The companies will be working with University of Minnesota and try to figure out the role of hydroxychloroquine as a preventive medicine .The drug is already in use as a treatment for several diseases like lupus,rheumatoid arthritis ,several types of Malaria etc 
Dr David Boulaware from University of Minnesota along with his research team will be conducting the experiment on 1,500 household workers and healthcare professionals with high risk of contamination.
According to him, “New drugs could save the lives of severely ill patients, and given prophylactically, can also protect healthcare workers and others at high risk of infection,” said Dr Boulware in commenting on the partnership. “We are grateful for the fast-track support of industry with this important study and believe our efforts will provide important answers about dealing with this virus.”
Vimal Kavuru, CEO, Rising Pharmaceuticals said, “We started talking to the University of Minnesota just over a week ago and have fast tracked our efforts to support this critically needed study. We are actively supporting research in this area to help build better clinical guidelines” while Dr Satyanarayana Chava, CEO, Laurus Labs added, “We are proud to assist this reputable institution and assist in the ongoing search for effective therapeutics against this global pandemic. We hope this research will underscore the clinical benefit of this drug in protecting our brave healthcare workers.”
Tags : #COVID19 #Universityofminnesota #Treatment #Hydroxychloroquine #LaurusLabs #Risingpharma #Collaboration

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026